Log in to save to my catalogue

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggre...

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c76717b318a742faa83e043eb3df2200

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

About this item

Full title

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

Publisher

Germany: BioMed Central Ltd

Journal title

Clinical epigenetics, 2023-08, Vol.15 (1), p.121-121, Article 121

Language

English

Formats

Publication information

Publisher

Germany: BioMed Central Ltd

More information

Scope and Contents

Contents

Adrenocortical carcinoma is rare and aggressive endocrine cancer of the adrenal gland. Within adrenocortical carcinoma, a recently described subtype characterized by a CpG island methylator phenotype (CIMP) has been associated with an especially poor prognosis. However, the drivers of CIMP remain unknown. Furthermore, the functional relation betwee...

Alternative Titles

Full title

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c76717b318a742faa83e043eb3df2200

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c76717b318a742faa83e043eb3df2200

Other Identifiers

ISSN

1868-7083,1868-7075

E-ISSN

1868-7083,1868-7075

DOI

10.1186/s13148-023-01534-5

How to access this item